两种具有螺旋结构的双核铜有机-无机配位聚合物的合成及表征

在水热和溶剂热条件下, 有机多齿羧酸4,4'-三苯胺二甲酸(H₂L)及含铜化合物分别与2,2'-联吡啶(bpy)和1,4-二(吡啶-4-甲氧基)苯(bpmb)反应, 合成了2种新型的含铜配位聚合物[Cu₂L(bpy)](1)和[CuL(bpmb)_0.5]·DMF(2). 通过X射线单晶衍射、 红外光谱、 元素分析、 热重和粉末X射线衍射分析等对其结构进行了表征. 结果表明, 化合物1属正交晶系, Pnma空间群, 其骨架为二维层状结构; 化合物2属单斜晶系, P2₁/c空间群, 具有{4⁴·6¹⁰·8}拓扑结构的三维网络.     

具有螺旋结构的金属镍有机-无机配位聚合物的合成及表征

在水热体系中合成了3个中心金属为镍离子, 以六配位扭曲八面体构型形成的具有螺旋结构的配位聚合物{[Ni₂L₂(bib)₂·2H₂O]·5H₂O}_n(1), [Ni₂L₂(bpy)]_n(2)和{[Ni₂L₂(bibpip)₂·2H₂O]·6H₂O}_n(3)[H₂L=4,4'-三苯胺二甲酸; bib=1,3-二(咪唑基)苯; bpy=4,4-联吡啶; bibpip=1,4-二(4-咪唑苄基)哌嗪]. 通过单晶及粉末X射线衍射、 红外光谱、 元素分析和热重分析对这3种化合物进行了表征. 结果表明, 化合物1属于单斜晶系, C2/c空间群, 其骨架为具有{4²·6⁵·8}拓扑结构的二维层结构; 化合物2属于斜方晶系, Fdd2空间群, 其骨架为具有{4⁸·5⁴·6³}拓扑结构的三维超分子网络; 化合物3属于三斜晶系, P\begin{array}{c}\bar{1}\end{array}空间群, 为1个五重穿插的三维超分子网络, 其骨架具有{4⁴·6²}拓扑结构.     

1-二茂铁基-3-[(9-乙基)咔唑-3-基]丙烯酮的合成及三阶非线性光学性质

合成了一个新的非线性光学(NLO)有机材料1-二茂铁基-3-[(9-乙基)咔唑-3-基]丙烯酮(FCAK),并通过NMR、IR、MS和元素分析等技术手段进行了表征。 采用粉末Nd∶YAG激光技术测定了标题化合物的三阶非线性光学性质并确定了相关参数。 激光脉冲为4 ns时,非线性折射率n₂=-3.5×10^-18 m²/W,非线性吸收系数β=-2.7×10^-11 m/W,三阶非线性极化率χ⁽³⁾=2.04×10^-12 esu,三阶非线性分子超极化率γ=1.1×10^-30 esu。 激光脉冲为21 ps时,n₂=0.55×10^-18 m²/W,β=-0.6×10^-11 m/W,χ⁽³⁾=3.4×10^-13 esu,γ=0.13×10^-30 esu。     

具有三核Cd(Ⅱ)簇单元和螺旋链的脯氨酸类单一手性金属-有机框架材料的合成、 结构和性质

在溶剂热反应条件下, 使用含氮辅助配体1,4-二(4-吡啶基)苯(1,4-DPB)和半刚性脯氨酸衍生物配体(R)-5-(2-羧基吡咯烷-1-羰基)间苯二甲酸[(R)-H₃PIA]或(S)-5-(2-羧基吡咯烷-1-羰基)间苯二甲酸[(S)-H₃PIA]与Cd²⁺构筑了单一手性金属-有机框架材料[Cd_1.5((R)-PIA)(1,4-DPB)_1.5]·0.75H₂O·xGuest(1-D)和[Cd_1.5((S)-PIA)(1,4-DPB)_1.5]·0.75 H₂O·xGuest(1-L). 配合物1-D和1-L呈具有开放孔道的三维柱层式框架结构, 含有三核镉簇单元 Cd₃(CO₂)₆与两种螺旋链构建的波浪形Cd-PIA层. 分别对上述化合物进行了粉末X射线衍射、 热重分析、 圆二色谱和荧光光谱等测试. 测试结果显示配合物1-D和1-L都是以纯晶体的形式存在, 2种配合物的热失重曲线接近, 圆二色谱有明显的正负吸收峰, 符合其对映体的结构特征.     

基于半刚性乳酸衍生物的单一手性配位聚合物的合成、 结构与性质

在溶剂热反应条件下, 用预先合成的乳酸衍生物(R)-H₂CBA和(S)-H₂CBA分别与含氮辅助配体(E)-1,2-二(4-吡啶基)乙烯(DPEE)和1,4-二(1H-咪唑-1-基)苯(1,4-DIB)组合, 制备出2对不同结构的单一手性配位聚合物[Cd₂((R)-CBA)₂(DPEE)(H₂O)₂]_n(1-D), [Cd₂((S)- CBA)₂(DPEE)(H₂O)₂]_n(1-L), [Cd((R)-CBA)(1,4-DIB)]·H₂O(2-D)和[Cd((S)-CBA)(1,4-DIB)]·H₂O(2-L). 其中1-D和1-L是由梯形Cd-CBA链和DPEE配体连接成的二维框架结构; 而2-D和2-L是三维超分子框架结构, 包含3种不同类型的对映手性螺旋链. 对上述化合物进行了粉末X射线衍射、 热重分析和圆二色谱分析, 并对其荧光性质进行了讨论.     

芘基查尔酮的合成及三阶非线性光学性质

合成了一种新的具有潜在应用价值的非线性光学(NLO)有机材料1-(芘-1-基)-3-(4-二甲氨基苯基)丙烯酮(PMAK),并通过 NMR、IR、MS和元素分析等技术手段进行了表征。 采用溶液Nd:YAG激光技术测定了PMAK的三阶非线性光学性质并确定了相关参数。 纳秒实验结果:折射率n₂=-3.5×10^-17 m²/W,吸收系数β=7.0×10^-10 m/W,极化率χ⁽³⁾=2.54×10^-11 esu,分子超极化率γ=3.44×10^-30 esu;皮秒实验结果:n₂=-2.8×10^-18 m²/W,β=8.3×10^-11 m/W,χ⁽³⁾=2.49×10^-12 esu,γ=3.33×10^-31 esu。     

新型不对称双席夫碱化合物的合成及其晶体结构

采用“一锅法”,小分子NH₃和水杨醛分别与2-氨甲基吡啶和4-氨甲基吡啶经缩合反应合成了两种新型的不对称双席夫碱化合物--2-{1,2-二［(E)-2-羟基苯亚甲氨基］-2-(2-吡啶基)乙基}苯酚(2a)和2-{1,2-二［(E)-2-羟基苯亚甲氨基］-2-(4-吡啶基)乙基}苯酚(2b),其结构经¹H NMR, ¹³C NMR, IR和X-射线单晶衍射(2b)表征。2b(CCDC： 1 423 247)属单斜晶系,P2(1)/n空间群,晶胞参数a=10.764(3) , b=9.725(2) , c=21.934(5) , β=93.291(9) °, V=2 292.2(9) ³, Dc=1.268 mg·cm^-3, Z=4, F(000)=920, μ=0.084 mm^-1。     

亚磷酸锌无机-有机杂化化合物的合成与结构表征

在水热条件下, 以1,6-己二胺为模板剂合成了一个三维(3D)亚磷酸锌无机-有机杂化化合物(C₆N₂H₁₆)_0.5ZnHPO₃(ZnHPO-CJ15), 并对其单晶结构进行了解析. 结果表明, ZnHPO-CJ15晶体属单斜晶系, P2₁/c空间群, a=1.19587(7) nm, b=0.82766(5) nm, c=0.77756(5) nm, α=90.00°, β=95.8370(10)°, γ=90.00°, V=0.76562(8) nm³, Z=1. ZnHPO-CJ15具有层柱状结构, 其骨架结构是由ZnO₃N四面体和HPO₃假四面体连接构成的二维4×8元环网层结构, 层与层之间由1,6-己二胺分子与Zn配位柱撑连接形成三维结构.     

超支化双吡啶亚胺铬催化剂的合成及催化乙烯齐聚性能

以1.0代(G)超支化大分子(C₃₈H₅₁N₉O₂)为配体骨架,2-氯-4-甲基吡啶和CrCl₃(THF)₃为原料,依次经过取代和配合反应合成了一种超支化双吡啶亚胺配体及其铬催化剂。 利用紫外-可见光谱(UV-Vis)、傅里叶变换红外光谱(FT-IR)、电喷雾电离质谱(ESI-MS)、核磁共振氢谱(¹H NMR)和元素分析等方法对其进行表征。 结果与理论设计预期一致。 考察了反应温度、乙烯压力、Al与Cr摩尔比(n(Al)/n(Cr))、溶剂及助催化剂种类等因素对催化剂催化乙烯齐聚性能的影响。 结果表明,以甲苯为溶剂,甲基铝氧烷(MAO)为助催化剂,当反应温度为45 ℃,乙烯压力为4 MPa,n(Al)/n(Cr)=300,催化剂用量为7 μmol时,活性可达1.32×10⁵ g/(mol(Cr)·h),C₆和C₈的选择性为59.30%。     

基于二茂铁的两个查尔酮衍生物的合成及超快三阶非线性光学响应

二茂铁是合成新颖有机功能材料的基本单元之一。 本文设计并合成了两个基于二茂铁的同分异构查尔酮衍生物:1-二茂铁基-3-(噻吩-2-基)丙烯酮(a)和1-二茂铁基-3-(噻吩-3-基)丙烯酮(b)。 采用超快激光Z-扫描技术(脉宽180 fs,波长532 nm)测定了化合物a和b的三阶非线性光学性质。 结果表明,化合物a吸收系数β=-2.1×10^-12 m/W,折射率n₂=1.9×10^-19 m²/W,分子超极化率γ=5.37×10^-32 esu;化合物b:β=-1.2×10^-13 m/W,n₂=2.0×10^-19 m²/W,γ=4.48×10^-32 esu。 说明在飞秒激光激发下,电荷转移能够在化合物a和b分子内部快速进行,二者均具有优异的超快三阶非线性光学响应。 在B3LYP/6-311+G(d,p)理论水平下,计算了化合物a和b分子轨道能量、极化率和各基团在前线分子轨道中的占有率。 理论计算结果显示,二茂铁基团在化合物a和b前线分子轨道中占有率分别为97%和98%,对两化合物的非线性光学性能起主导作用。     

Preparation of both enantiomers of malic and citramalic acid and other hydroxysuccinic acid derivatives by stereospecific hydrations of cis or trans 2-butene-1,4-dioic acids with resting cells of Clostridium formicoaceticum

(R)-Malic, (S)-malic, (R)citramalic, (S)-citramalic, (2R,3S)-2-hydroxy-3-methyl-succinic and (2R,3S)-2,3-dimethyl-2-hydroxysuccinic acid were prepared on scales up to 25 mmol by stereospecific addition of water to different 2-butene-1,4-dioic acid derivatives catalyzed by resting cells of Clostridium formicoaceticum (Scheme 1). The (3R)-monodeuterio (R)- and (S)-malic acid as well as (R)- and (S)-citramalic acid were prepared using freeze-dried cells in ²H₂O-buffer. The stereochemical purity of the products was in most cases ≥ 99%.     

Preparation of (S)-2-substituted succinates by stereospecific reductions of fumarate and derivatives with resting cells of Clostridium formicoaceticum

Fumarate derivatives have been reduced to (S)-2-methylsuccinate 2a, (S)-2-ethylsuccinate 3a and (S)-2-chlorosuccinate 4a in up to 1 M concentrations with Clostridium formicoaceticum. Formate was the electron donor and viologens or anthraquinone-2,6-disulphonate acted as artificial electron mediators. Reductions with freeze-dried cells in ²H₂O-buffers led to the (2R,3S)-[2,3-2,²H]-dideuterated succinate derivatives. The productivity numbers¹ ranged from 450 to 5000 and the enantiomeric excess of all (S)-2-substituted succinates was 99 %.     

Tris-chelate complexes with chiral ligands: In search of diastereoisomeric selectivity with remote stereogenic centres

The chiral ligands, 4,4′-bis{(1S,2R,4S)-(−)-bornyloxy}-2,2′-bipyridine, (1S,2R,4S)-1, and 4,4′-bis{(1R,2S,4R)-(+)-bornyloxy}-2,2′-bipyridine, (1R,2S,4R)-1, have been prepared and characterized by spectroscopic techniques and, for (1S,2R,4S)-1, by single crystal X-ray diffraction. Despite the use of enantiomerically pure ligands, the formation of the complexes [Fe((1S,2R,4S)-1)₃]²⁺, [Ru((1S,2R,4S)-1)₃]²⁺, [Ru((1S,2R,4S)-1)(bpy)₂]²⁺ and [Ru((1R,2S,4R)-1)(bpy)₂]²⁺ proceeds without preference for either the Δ or Λ-diastereoisomers.     

Indenyl complexes of ruthenium(II) containing optically active diphosphines. X-ray structures of (S,S)-(η-C9H7)-Ru{Ph2PCH(CH3)CH(CH3)PPh2}Cl and of its η-C5H5 analogue

The optically active indenyl complexes ((η⁵-C₉H₇)Ru(L---L)Cl (where L---L is either (S,S)-1,2-dimethyl-1,2-ethanediylbis(diphenylphosphine) (chiraphos) or (R,R)-1,2-cyclopentanediylbis(diphenylphosphine) (cypenphos)) have been synthesized and spectroscopically characterized and compared with the corresponding cyclopentadienyl complexes. Reaction of the new complexes with 2-e-donors give cationic adducts in which the pentahaptocoordination of the indenyl ligand is maintained. The crystal structures of (S,S)-(η⁵-C₉H₇)Ru{Ph₂PCH(CH₃)CH(CH₃)PPh₂}Cl (1) and (S,S)-η⁵-C₅H₅Ru{Ph₂PCH(CH₃)CH(CH₃)PPh₂}Cl (3) have been determined.     

Catalytic and structural studies of Rh complexes of (−)-(2S,4S)-2,4-bis(diphenylphosphino)pentane. Asymmetric hydrogenation of acetophenonebenzylimine and acetophenone

Rhodium(I) complexes formed by (−)-(2S,4S)-2,4-bis(diphenylphosphino)pentane (BDPP) are efficient catalysts for the hydrogenation of acetophenone and acetophenonebenzylimine. The composition of the solvent mixture and the reaction temperature have a marked influenced on the enantioselectivity. These effects are thought to be related to the enhanced conformational flexibility of six-membered rings when simple substrates without functional groups are coordinated to the rhodium. X-ray crystallographic studies reveal that in [Rh((S,S)-BDPP)NBD]⁺ (1) the ligand is in a chair conformation, and that in [Rh((S,S)-BDPP)COD]⁺ (2) the chelate ring is in a δ-skew conformation. Studies of Rh((S,S)-BDPP)(NBD)Cl (3) in solution indicate a trigonal bipyramidal structure with a chair conformation of the ring in aromatic solvents and a conformationally labile ring in methanol.     

Efficient regioselective labelling of the CFC alternative 1,1,1,2-tetrafluoroethane (HFC-134a) with fluorine-18

Efficient chemistry is described for the regioselective labelling of the CFC alternative 1,1,1,2-tetrafluoroethane with cyclotron-produced positron-emitting fluorine-18 (t_1/2 = 109.7 min). [1-¹⁸F]1,1,1,2-Tetrafluoroethane was prepared by nucleophilic addition of no-carrier-added [¹⁸F]fluoride to trifluoroethylene and [2-¹⁸F]1,1,1,2-tetrafluoroethane by nucleophilic displacement of tosylate with [¹⁸F]fluoride in 2,2,2-trifluoroethyl p-toluenesulphonate. Each reaction was mediated by a potassium cation-Kryptofix^® 2.2.2 complex, with or without acetonitrile as solvent, in a sealed glassy carbon vessel. The selectivities were 97.2±0.4% for labelling in the 1-position by nucleophilic addition and 91.2±1.2% for labelling in the 2-position by nucleophilic substitution. GC separation afforded each labelled tetrafluoroethane in high radiochemical purity (>99.995%) and high chemical purity (>99.6%). Specific radioactivities of about 37 MBq (1 mCi) per μmol were obtained. Each synthesis was fully automated to cope safely with the high initial radioactivity and delivered purified product within one physical half-life of the fluorine-18 The products are suitable for pharmacokinetic studies in man.     

Novel sesquiterpenes and a lactone from the Jamaican sponge Myrmekioderma styx

Two novel sesquiterpenes, styxone A (1) and styxone B (2), and a novel lactone, styxlactone (3), were isolated from the Jamaican sponge Myrmekioderma styx. Their structures were elucidated by detailed ¹H, ¹³C and 2D NMR data and the absolute stereochemistry of styxone A and B was determined by CD spectra. Styxone A represents a novel sesquiterpene skeleton. (S)-(+)-Curcuphenol (4), (S)-(+)-curcudiol (5), and abolene (6) were also isolated. An activity enhancement by cyanthiwigin B (7) to curcuphenol was observed in the antimicrobial assays when the two compounds were administered together.     

Pictet-Spengler reaction of biogenic amines with (2R)-N-Glyoxyloylbornane-10,2-sultam. Enantioselective synthesis of (S)-(+)-N-methylcalycotomine

(2R)-N-Glyoxyloylbornane-10,2-sultam reacted with dopamine hydrochloride, forming the Pictet-Spengler condensation product, which was further converted into (S)-(+)-N)-methylcalycotomine of high enantiomeric purity. The same kind of reaction with tryptamine hydrochloride gave the condensation product with 100% d.e.     

Enantioselective organic syntheses using chiral transition metal complexes V. (2S,3S)-Bis(dibenzophospholyl)butane, a rigid (S,S)-CHIRAPHOS analog

The P–Ph cleavage of phenyldibenzophosphole (1) with lithium in THF gives lithium dibenzophospholide (2). Reaction of 2 with ethyleneglycol ditosylate produces the known chelate ligand 1,2-bis(dibenzophospholyl)ethane (3) in good yield. Similarly, 2 and (2R,3R)-butanediol ditosylate give the new chiral chelate ligand (2S,3S)-bis(dibenzophospholyl)butane (4). Ligand exchange of [CpRu(PPh₃)₂Cl] with 3 or 4 yields the halfsandwich complexes [CpRu(C₁₂H₈PC₂H₄PC₁₂H₈)Cl] (5) and [CpRu((S,S)-C₁₂H₈PCHMeCHMePC₁₂H₈)Cl] (6). Complex 6 was characterized crystallographically (monoclinic, space group P2₁ (no. 4), a=820.6(4), b=1501.0(3), c=1172.8(6) pm, β=108.87(2)°, V=1.367(1)×10⁹ pm³, Z=2). The most conspicuous feature of the structure of 6 is the perfect coplanarity of the two dibenzophosphole moieties imposed by their steric interaction with the Cp ligand. Complex 6 and the thiophene complex [CpRu((S,S)-C₁₂H₈PCHMeCHMePC₁₂H₈)(SC₄H₄)]BF₄ (7) derived therefrom are remarkably unreactive with regard to ligand substitutions. A possible explanation is the lack of intramolecular

Full-size image

–C stabilization en route to the transition state of ligand substitution. The enantiomeric purity of 6 and 7 could nevertheless be demonstrated by conversion to diastereomerically pure [CpRu((S,S)-C₁₂H₈PCHMeCHMePC₁₂H₈)((S)-CNCHMePh)]BF₄ (8).     

Homochiral cyclopentane-based C1-symmetric P,P ligands C5H8(PPh2)(PR2) from C2-symmetric C5H8(PCl2)2

Treatment of 1,2-trans-C₅H₈(PCl₂)₂ with 1,2-C₂H₄(NHPr-i)₂ gave the C₂-symmetric perhydro-1,6,2,5-diazaphosphocine C₅H₈{P(Cl)N(Pr-i)CH₂}₂-cyclo, which produced dissymmetric C₅H₈(PPh₂){P[N(Pr-i)CH₂]₂-cyclo} on further reaction with PhMgBr. Cleavage of the P---N bonds with gaseous HCl afforded C₅H₈(PPh₂)(PCl₂), which was converted to C₅H₈(PPh₂){P(OPh)₂}₂ by reaction with phenol. All chiral P,P derivatives were obtained as racemates as well as resolved (1R,2R)- and (1S,2S)-enantiomers.